Ads
related to: atopic dermatitis- FAQs
Find Answers To Your Questions
& Understand Treatment Now
- Home
Official Patient Website—
Get Treatment Info Today.
- Treatment Support
Discover Educational Resources
& Get Financial Support Information
- Support Resources
Sign Up And Learn More About The
Patient Education Program Today.
- Getting Started
Learn More About Dosing Schedules
Find Answers To Your Questions
- Sign Up
Register Or Activate Your Card—
Find Out If You're Eligible Today.
- FAQs
Search results
Earnings call: Nektar Therapeutics optimistic on REZPEG and pipeline progress By Investing.com
Investing.com· 7 hours agoNektar Therapeutics (NASDAQ:NKTR) reported a productive first quarter of 2024, focusing on their...
Earnings call: Aclaris Therapeutics progresses with atopic dermatitis study By Investing.com
Investing.com· 2 days ago:ACRS) has announced during its First Quarter 2024 Conference Call that it will advance ATI-2138,...
Systemic antibiotics in first year of life tied to higher atopic dermatitis risk
Medical Xpress· 2 days agoSystemic antibiotic exposure in the first year of life is associated with higher atopic dermatitis...
RAPT Therapeutics Shares Hit 52-Week Low After Trials Closed
Morningstar· 1 day agoThe immunology-based therapeutics company said it has decided to close and unblind both its Phase 2b clinical trial of zelnecirnon in atopic dermatitis ...
BofA bullish on Apogee stock, sees significant market growth potential By Investing.com
Investing.com· 9 hours agoFriday, BofA Securities initiated coverage on Apogee (NASDAQ:APOG) Therapeutics Inc (NASDAQ:APGE)...
...Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients During Virtual...
Benzinga· 3 days agoThe KOL event, "Treatment Options for Atopic Dermatitis Patients with an Inadequate Response to Dupilumab: Exploring the ...
Jefferies raises Nektar Therapeutics stock target, maintains hold By Investing.com
Investing.com· 5 hours agoThe adjustment comes as Nektar Therapeutics progresses with its clinical trials. The company is...
What's Going On With Dermatitis-Focused RAPT Therapeutics Stock On Thursday?
Benzinga via Yahoo Finance· 1 day agoOn Thursday, RAPT Therapeutics Inc. (NASDAQ:RAPT) announced that it has decided to close and unblind...
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 9 hours agoBofA initiated coverage of Apogee Therapeutics (APGE) with a Buy rating and $80 price target. The...
Nektar's (NKTR) Q1 Earnings and Revenues Surpass Estimates
Zacks via Yahoo Finance· 7 hours agoRezpeg is now a wholly owned asset of Nektar and the company owes no royalty payments to LLY. A...
Ads
related to: atopic dermatitis